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Indoor dampness and mould health effects – ongoing questions 
on microbial exposures and allergic versus nonallergic 
mechanisms
J. M. Cox-Ganser
Division of Respiratory Disease Studies, National Institute for Occupational Health, Morgantown, 
WV, USA
For some time now, it has been apparent that living, working, or going to school in damp 
buildings is associated with adverse health effects. In 2004 and 2009, two major reviews 
were published relating to health effects and damp indoor environments. These were the 
Institute of Medicine (IOM) report [1] and the World Health Organization (WHO) 
guidelines for dampness and mould [2]. In 2011, a follow-up review to the WHO guidelines 
was published [3]. These three publications documented that occupants of damp indoor 
environments are at risk for upper and lower respiratory symptoms, onset and exacerbation 
of asthma, respiratory infections, hypersensitivity pneumonitis, allergic rhinitis, eczema, and 
bronchitis.
The IOM report covered pertinent literature published up to late 2003 on a wide range of 
health effects including asthma. The findings regarding asthma were that sufficient evidence 
existed for associating the presence of mould or other agents in damp buildings with asthma 
exacerbations and that limited or suggestive evidence existed for associating exposure to 
damp indoor environments with asthma development. The committee concluded that 
excessive indoor dampness is a public health problem and that prevention or reduction of 
this condition should be a public health goal.
The WHO guidelines report covered literature published up to July 2007 on a number of 
health effects including asthma. Regarding asthma, it was concluded that there is sufficient 
epidemiological evidence of an association between indoor dampness-related factors and 
asthma development, asthma exacerbation, and current asthma. These findings were upheld 
in an updated review [3]. Recommendations from the WHO document included ‘Persistent 
dampness and microbial growth on interior surfaces and in building structures should be 
avoided or minimized, as they may lead to adverse health effects’. The review paper by 
Mendell and colleagues in 2011 had as one conclusion that ‘prevention and remediation of 
indoor dampness and mould are likely to reduce health risks’.
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A 2007 meta-analysis of 33 studies estimated that exposure to dampness and mould in the 
home raises the risk for asthma development, ever diagnosed asthma, and current asthma by 
about 30–50% [4]. It has been estimated that 21 per cent of U.S. current asthma cases are 
attributable to dampness and mould, which translates to 4.6 million of 21.8 million U.S. 
current asthma cases attributable to dampness and mould [5]. This study also estimated the 
annual cost of asthma attributable to dampness and mould exposure at $3.5 billion.
Another meta-analysis of 16 studies published between 1998 and 2011 found that the risk of 
developing asthma increases in relation to exposure to dampness and mould present in 
homes before the onset of the disease [6]. The 16 studies were cohort or incident case–
control designs on infants (seven studies), children (seven studies), or adults (two studies). 
The presence of asthma in most studies was evaluated from self (or parent) reports of 
wheezing (in infants), doctor-diagnosed asthma, doctor-diagnosed bronchial obstruction, 
obstructive or asthmatic bronchitis or asthma (only asthma in infants), and asthma 
attacks/use of asthma medication. Two studies included the use of lung function testing. The 
signs of water damage, dampness, and mould in the homes were reported by the occupants 
only (nine studies) or by inclusion of home inspection (seven studies). The overall summary 
of odds ratio (OR) for the relationship between onset of asthma and any sign of exposure 
was 1.50 (95% CI 1.25–1.80) based on the use of the highest effect estimates from 16 
studies, while it was 1.31 (95% CI 1.09–1.58) based on the lowest reported effect estimates. 
A higher OR was found for the home inspection exposure estimates than for the self-
reported exposures; 2.24 (95% CI 1.70–3.41) vs. 1.29 (95% CI 1.11–1.48), which argues 
against the associations being due to reporting bias. Separate analyses on the different signs 
of exposure found that the ORs ranged from lowest to highest for water damage (OR 1.12; 
95% CI 0.98–1.27), dampness (OR 1.33; 95% CI 1.12–1.56), visible mould (OR 1.29; 95% 
CI 1.04–1.60), and mould odour (OR 1.73; 95% CI 1.19–2.50). This result was hypothesized 
to indicate that the microbial contamination causal to the health effect increases with 
prolonged dampness.
In this issue of Clinical and Experimental Allergy, Sharpe and colleagues [7] used existing 
population-based data on 2849 children aged 6–18 and 5563 adults from the U.S. National 
Health and Nutrition Examination Survey (NHANES) in 2005–2006. They investigated the 
associations between self-reported asthma, allergies, and eczema and exposures to self-
reported mildew/musty odours in the home, and house dust concentrations of two species of 
fungi (Aspergillus fumigatus and Alternaria alternata), endotoxin (a cell wall component of 
gram negative bacteria), and dust mite, dog, cat, and cockroach antigens. They also 
examined serum levels of total IgE and allergen-specific IgE in relation to health outcomes. 
There were no major findings between the range of dust measures of contaminants and 
health outcomes, including for the two fungal species. The most consistent finding was that 
mildew/musty odour in the home was positively associated with childhood asthma (OR 
1.60; 95% CI 1.17–2.19), adult eczema (OR 1.92; 95% CI 1.39–2.63), allergy (OR 1.59; 
95% CI 1.26–2.02), and asthma (OR 1.61; 95% CI 1.00–2.57). Interestingly, there was a 
difference between children and adults in the association between mildew/musty odour and 
asthma when the models were stratified by level of total serum IgE. In children, the 
association was stronger in those with total IgE levels ≥170 KU/L, while in adults, the 
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association was only found in those with total IgE levels <170 KU/L. As the authors 
speculate, this finding is consistent with indoor fungal contamination being associated with 
both allergic and nonallergic asthma depending on the age of the occupants. In contrast, 
adult eczema and allergy were associated with the mouldy odours, perhaps indicating 
complex allergic and nonallergic responses to fungal exposures in the indoor environment. 
In addition, the authors found some evidence that being exposed to a higher number of 
different contaminants in the dust conferred a protective effect for childhood eczema and 
adult asthma.
Two issues of interest arising from the report by Sharpe and colleagues are the role of 
various indoor exposures in either causal or protective health effects and the range of 
allergenic and nonallergenic mechanisms involved in health outcomes. As they were using 
existing data, Sharpe and colleagues were limited in the microbial diversity they could 
assess in relation to health effects, and it is perhaps no surprise that the presence of mouldy 
odours, which indicates active microbial growth, was the best surrogate of exposure to 
fungal contamination, or at the very least a good indication of excessive dampness in the 
homes. It is currently not understood which specific contaminants or combinations thereof in 
damp indoor environments cause the various health effects, and results are inconsistent from 
study to study. In a recent review, Sharpe and colleagues [8] concluded there is some 
evidence that in indoor environments, Penicillium, Aspergillus, Cladosporium, and 
Alternaria species are associated with asthma outcomes, but that more work is needed on the 
role of fungal diversity. Earlier work in the United States by investigators from the National 
Institute for Occupational Safety and Health showed that in occupants of a historically 
water-damaged large office building asthma was associated with concentrations of water-
loving (hydrophilic fungi) in floor dust [9] and that there was a synergistic effect between 
fungal exposure and endotoxin exposure in relation to respiratory health effects [10]. Other 
analyses on this same office building population found evidence for a nonallergic 
mechanism of building-related asthma, in that the presence of posthire onset asthma was 
associated with a lower prevalence of positive skin prick reactions to common aero-
allergens including indoor and outdoor mould mixes [11].
Data from large cross-sectional studies of approximately 46,000, 8–12-year-old children in 
20 countries during phase two of the International Study of Asthma and Allergies in 
Childhood (ISAAC) were analysed for associations between dampness and visible mould in 
homes and respiratory and allergic symptoms [12]. Both symptoms and home dampness/
mould were reported by home occupants on questionnaire. There were significant and 
consistent associations between current exposure and wheeze (OR 1.58; 95% CI 1.4–1.79), 
coughing up phlegm without a cold (OR 1.90; 95% CI 1.59–2.26), rhinitis (OR 1.51; 95% 
CI 1.37–1.66), rhinoconjunctivitis (OR 1.61; 95% CI 1.42–1.83), and reported eczema (OR 
1.52; 95% CI 1.34–1.73). There were no indications of effect modification by parental atopy 
and skin prick testing of the children (n = 26,967) for sensitization to house dust mites, cat 
dander, Alternaria alternata, mixed tree pollen, and mixed grass pollen. The authors 
interpreted these results to indicate that the effects of dampness/mould on health were 
mainly due to nonallergic mechanisms.
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A 9-year prospective follow-up study for onset of asthma was conducted on 7104 young 
adults from 13 countries who had participated in the European Community Respiratory 
Health Survey (ECRHS I and II) and had not reported respiratory symptoms or asthma at 
baseline [13]. Dampness and mould in the homes were assessed at baseline and at the end of 
follow-up by questionnaire and at the end of follow-up by building inspection for a subset of 
2602 homes. A participant was considered to have new-onset asthma if in the follow- up 
questionnaire (s)/he answered ‘yes’ to one or more of three questions on attacks of asthma in 
the last 12 months, using asthma medication, or being woken by an attack of shortness of 
breath in the last 12 months. This definition was met by 355 (5%) of participants. A second 
definition included fulfilment of the first definition and evidence of bronchial 
hyperresponsiveness (BHR) from testing carried out at follow-up, and this was met by 56 
(0.8%) of participants. Exposure variables included: baseline reports of any water damage in 
the last 12 months, any mould growth in the last 12 months, ever any mould growth in the 
bedroom, and ever any mould growth in the living room; the same questions but combined 
from the baseline and follow-up survey; reports on damp spots in the last 12 months (only 
asked at follow-up); and observed damp spots and visible mould from the home inspections. 
Self-reported water damage or mould was common, with 49.7% reporting water damage and 
41.7% reporting mould either at baseline or follow-up. Statistically significant associations 
for new-onset asthma (not including BHR) were found for both self-reported (at baseline 
and for both surveys) with relative risks (RR) from 1.28 to 1.48 and home inspection 
findings of damp spots with a RR of 1.49 (95% CI 1.00–2.22). Among participants who had 
not moved houses over the follow-up period, new-onset asthma combined with BHR was 
associated with self-reported mould in the bedroom (RR 2.64; 95% CI 1.10–6.33) and self-
reported mould in the living room (RR 3.79; 95% CI 1.64–8.73). Higher RRs for new-onset 
asthma were found for participants who were skin prick positive for Cladosporium 
herbarum and Alternaria alternata at baseline. For example, for water damage in the last 12 
months (reported at either baseline or follow-up surveys), the RR for participants with no 
sensitization was 1.60 (95% CI 1.07–2.39), while for those sensitized to mould the RR was 
4.57 (95% CI 2.10–9.94).
There are few published intervention studies in relation to dampness/mould and asthma in 
homes, and more research in this area is needed as it speaks to the efficacy of following 
guidelines to remediate dampness and mould to reduce adverse health effects. A randomized 
controlled trial of asthmatic children in the United States examined the effects of 
remediation of damp and mould contaminated home environments [14]. Two- to 17-year-old 
children with asthma were recruited from a paediatric hospital in Cleveland, OH, and were 
required to be living in a home with visible mould based on an inspection. Children were 
randomized to remediation (N = 29) and control groups (N = 33), and their asthma 
symptoms and medical visits were tracked for 12 months. Home remediation included the 
removal of mould from hard surfaces, elimination of rainwater intrusion, installation of 
ventilation systems to exhaust water vapour from kitchens and bathrooms, and repair of 
plumbing leaks. There was a significant reduction in symptomatic days per month for the 
remediation group compared to the control group during the 10th and 12th month of the 
study. In addition, during the postremediation period, there were significantly fewer 
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emergency department visits and/or hospitalizations among children in the remediation 
group (4%) compared to the control group (33%).
Another randomized control trial in Britain (South Wales) studied 164 houses with 
dampness/mould, each with at least one occupant with asthma (232 asthma patients between 
3 and 61 years old) [15]. Houses were randomly allocated to an intervention group (N = 81) 
and a control group (N = 83). Intervention consisted of visible mould removal, treatment 
with fungicide, and installation of a fan in the loft to improve ventilation. Health 
questionnaires were given, and peak flow rates were measured, at baseline, 6 months and 12 
months after randomization. Asthma symptoms and asthma medication use declined in the 
intervention group, but no difference was found between intervention and control groups in 
changes in variability of peak flow.
More recently, Takaro and colleagues studied the effects of moving into an ‘asthma-
friendly, Breathe- Easy home (BEH)’ on asthma outcomes in children [16]. This study had a 
quasi-experimental design where outcomes of children in a BEH (n = 34) were compared 
with those of a matched comparison group (n = 68). The BEHs had exterior envelopes 
designed to avoid moisture intrusion, interior materials that minimized dust and off-gassing, 
and a ventilation system with filtration and continuous fresh air supply. The children who 
moved into the BEHs had increases in asthma-free days, from 8.6 per 2 weeks in the 
previous home to 12.4 per 2 weeks after 1 year in the BEH. Furthermore, the proportion of 
BEH children with asthma-related urgent healthcare visits in the past 3 months decreased 
from 62% to 21%.
In the USA, three governmental or professional bodies issued recent reports highlighting the 
health effects related to the occupancy of damp indoor environments: (1) The National 
Institute for Occupational Safety and Health issued an Alert on Preventing Occupational 
Respiratory Disease from Exposures Caused by Dampness in Office Buildings, Schools, and 
other Nonindustrial buildings [17]. This document includes a section on current standards 
and recommendations in the United States. (2) The American Society of Heating, 
Refrigerating and Air-Conditioning Engineers (ASHRAE) released a position document on 
limiting indoor mould and dampness in buildings which states that: ‘Credible research and 
cognizant health authorities have established an association between health problems and 
indoor dampness. A building’s mechanical systems, its exterior enclosure, and its occupant 
activities all affect the amount of wetting and drying indoors. Therefore, ASHRAE takes the 
position that all policymakers, regulatory authorities, building professionals, and building 
occupants should be aware that indoor dampness, mould, and microbial growth are warnings 
of potential problems’ [18]. 3) The American Industrial Hygiene Association (AIHA) 
released a position statement on mould and dampness in the built environment, which uses 
the evidence for health effects associated with damp indoor environments to conclude that 
persistent dampness and mould damage in the nonindustrial workplace, including schools 
and residential housing, requires prevention, management and effective remediation [19].
As discussed by Sharpe and colleagues in their report in this issue, there is much to learn 
about the role of exposure to microbial agents from diverse microbiomes in both the natural 
and built environment in relation to development and adaptation of our immune systems and 
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how we cope with changes in such exposures at all stages of our lives. While research in 
these areas continues, it is prudent from a public health standpoint to recognize that damp 
and mouldy indoor environments are unhealthy and should be remediated or prevented in 
the first place with appropriate building design and maintenance.
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